Table 2 Biochemical parameters levels in diabetic patients and healthy control subjects.

From: Potential role of serum copeptin among smoker T2DM patients with emphasis to ACE I/D gene polymorphism predicting DN

Parameters

Diabetic patients (n = 106)

Healthy Control (n = 102)

t Test

P value

Fasting s. glucose (mg/dL

165.11 ± 84.76

90.37 ± 20.80

8.66

 < 0.001

HbA1C (%)

7.34 ± 1.46

5.26 ± 0.71

10.45

 < 0.001

Serum KIM-1 (ng/mL)

30.29 ± 15.26

24.78 ± 8.73

2.95

 < 0.004

Serum Copeptin (ng/mL)

567.10 ± 125.45

472.74 ± 102.38

5.54

 < 0.001

Serum Chol (mg/dL)

179.37 ± 46.85

132.97 ± 42.32

7.14

 < 0.001

Serum TG (mg/dL)

197.10 ± 76.60

137.48 ± 66.87

5.71

 < 0.001

uPb (ng/mg creat)

0.34 ± 0.44

0.19 ± 0.14

2.66

 < 0.009

eGFR (mL/min/1.73m2)

120.13 ± 40.67

132.57 ± 25.83

2.5

 < 0.012

Back to article page